VANGUARD GROUP INC 13D and 13G filings for Teladoc Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 17,514,904 10.580% | 201,376 (+1.16%) | Filing |
| 2023-07-10 10:41 am Purchase | 2023-06-30 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 17,313,528 10.580% | 2,837,373 (+19.60%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 14,476,155 8.940% | 1,336,093 (+10.17%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 13,140,062 8.210% | 1,666,403 (+14.52%) | Filing |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 11,473,659 7.920% | 2,412,050 (+26.62%) | Filing |
| 2020-11-10 11:51 am Purchase | 2020-10-30 | 13G | Teladoc Health, Inc. TDOC | VANGUARD GROUP INC | 9,061,609 10.740% | 2,393,556 (+35.90%) | Filing |